Other languages Orexo AB

Equities

ORX

SE0000736415

Market Closed - Nasdaq Stockholm Other stock markets 08:59:49 26/04/2024 pm IST			5-day change	1st Jan Change
16.54 ^SEK	-2.71%		+0.12%	+6.99%

17/04	Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment	MT
17/04	Orexo Extends Patent Protection for Its Nasal Epinephrine Powder Product OX640 in the US	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Orexo Extends Patent Protection for Its Nasal Epinephrine Powder Product OX640 in the US	17/04
Sweden's Orexo Set for Early Redemption of Bonds Due 2025	02/04
Orexo AB Announces Board Resignations	22/03
Orexo Issues SEK500 Million Social Bonds, Closes Tender Offer	14/03
Orexo Plans SEK500 Million New Social Bond Issuance, Tender Offer	08/03
Orexo, Swedish Orphan Biovitrum to Further Explore AmorphOX Combination	12/02
Orexo AB (Publ.) and Swedish Orphan Biovitrum AB (publ.) Agrees to Advance Feasibility Study with Amorphox	12/02
Orexo AB Reports Earnings Results for the Full Year Ended December 31, 2023	08/02
US FDA Approves New Drug Application for Orexo's Opioid Overdose Rescue Medication	28/11
Orexo AB Announces FDA Acceptance of New Drug Application Filing for OX124	28/11
Orexo AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	02/11
Orexo AB Announces Changes in the Board of Directors	27/23/27
Orexo AB Announces Nomination Committee Appointments	26/23/26
Orexo AB Announces Resignation of Robin Evers as A Board Member	26/23/26
Orexo's Opioid Use Disorder Drug Study Shows Unexpectedly High Treatment Response Rates	11/23/11
Orexo AB Announces Data from the MODIA Study Evaluating Impact on Use of Illicit Opioids	11/23/11
Orexo AB Announces Henrik Kjær Hansen Will Resign from the Board of Directors	02/23/02
Orexo Files New US Drug Application for Opioid Overdose Medication	18/23/18
Orexo AB (publ.) Submits New Drug Application to FDA for OX124, a High-Dose Rescue Medication for Opioid Over Overio Overio Overio Overio	18/23/18
Orexo Obtains First US Patent for Nasal Epinephrine Product	29/23/29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Orexo AB

Equities

ORX

SE0000736415

Other languages

Filters